
Why Early Detection Matters: The Science Behind Viome's New Pancreatic Cancer Test
Pancreatic cancer rarely shows symptoms early, which is why most cases are found too late. In this Halloween episode, Momo Vuyisich and Guru Banavar walk through survival by stage, the risk factors worth knowing (including new-onset type 2 diabetes), and how Viome turned an OHSU research discovery into a clinical test. Learn how a nanosensor detects active tumor enzymes in blood, what CLIA validation really involves, and how the test reached 86% early-stage sensitivity. Plus: no-knead bread and a simple salt swap.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.